- Home
- CELC vs EBC Comparison
CELC vs EBC Comparison
Compare CELC & EBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- EBC
- Stock Information
- Founded
- CELC 2011
- EBC 1818
- Country
- CELC United States
- EBC United States
- Employees
- CELC N/A
- EBC N/A
- Industry
- CELC Medical Specialities
- EBC Accident &Health Insurance
- Sector
- CELC Health Care
- EBC Finance
- Exchange
- CELC Nasdaq
- EBC Nasdaq
- Market Cap
- CELC 3.1B
- EBC 3.6B
- IPO Year
- CELC 2017
- EBC 2020
- Fundamental
- Price
- CELC $100.23
- EBC $19.00
- Analyst Decision
- CELC Strong Buy
- EBC Strong Buy
- Analyst Count
- CELC 7
- EBC 2
- Target Price
- CELC $95.29
- EBC $21.50
- AVG Volume (30 Days)
- CELC 916.2K
- EBC 2.8M
- Earning Date
- CELC 11-12-2025
- EBC 10-23-2025
- Dividend Yield
- CELC N/A
- EBC 2.73%
- EPS Growth
- CELC N/A
- EBC N/A
- EPS
- CELC N/A
- EBC 0.24
- Revenue
- CELC N/A
- EBC $627,584,000.00
- Revenue This Year
- CELC N/A
- EBC $27.03
- Revenue Next Year
- CELC N/A
- EBC $24.93
- P/E Ratio
- CELC N/A
- EBC $78.21
- Revenue Growth
- CELC N/A
- EBC 3.01
- 52 Week Low
- CELC $7.58
- EBC $13.51
- 52 Week High
- CELC $103.06
- EBC $19.31
- Technical
- Relative Strength Index (RSI)
- CELC 78.25
- EBC 64.55
- Support Level
- CELC $92.10
- EBC $17.28
- Resistance Level
- CELC $103.06
- EBC $19.31
- Average True Range (ATR)
- CELC 5.52
- EBC 0.51
- MACD
- CELC 0.74
- EBC 0.21
- Stochastic Oscillator
- CELC 90.84
- EBC 87.91
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.